Pardes Biosciences Inc.

NASDAQ: PRDS · Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM

Pardes Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
59.28M 268.68M
Short-Term Investments
138.06M n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
219K n/a
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
3.06M 6.58M
Total Current Assets
200.4M 275.26M
Property-Plant & Equipment
n/a n/a
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
219K n/a
Total Assets
200.62M 275.26M
Account Payables
4.93M 2.38M
Deferred Revenue
n/a n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
15.5M 6.58M
Total Current Liabilities
20.43M 8.96M
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
4.93M n/a
Total Liabilities
20.43M 8.96M
Total Debt
n/a n/a
Common Stock
6K 6K
Retained Earnings
-148.16M -51.52M
Comprehensive Income
-24K n/a
Shareholders Equity
180.2M 266.29M
Total Investments
138.06M n/a